News | May 05, 2026
Eton Pharmaceuticals relaunches HEMANGEOL with new distribution model
The company says the product will now be distributed exclusively through Anovo Specialty Pharmacy
The company says the product will now be distributed exclusively through Anovo Specialty Pharmacy
New Centre of Excellence at Electronic City campus to offer specialised care in epilepsy, cerebrovascular disorders, neurointervention, skull base and spine surgery
The newly established institute is equipped with advanced infrastructure designed to integrate multiple specialties under one roof
The initiative pairs consumer engagement with a public health message about prevention and early detection
The trials -- ELOWEN-1 and ELOWEN-2 -- are designed to evaluate the drug in people living with lupus who experience active skin manifestations
Gambhir brings over 35 years of rich experience in strategic finance, governance, business transformation, and leadership
Health innovations are viewed more positively than food and agricultural technologies
Q2 2026 analysis shows expanding approvals, stronger uptake, and a shift toward evidence-driven biosimilar evaluation
The first Phase III and second Phase III trials will be multi-centre, randomised, assessor-blind, active-comparator studies to determine the efficacy, safety and tolerability of orally administered Zintrodiazine
Over the past decade, IIL has maintained a strong growth trajectory, registering a compound annual growth rate (CAGR) of 16%
Subscribe To Our Newsletter & Stay Updated
